|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910960620403321 |
|
|
Titolo |
Lung transplantation : therapies, complications, and outcomes / / editors, Richard D. Ferguson and Craig A. Holmer |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Hauppauge, N.Y., : Nova Science Publishers, c2011 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (241 p.) |
|
|
|
|
|
|
Collana |
|
Organ transplantation research horizons |
|
|
|
|
|
|
Altri autori (Persone) |
|
FergusonRichard D. <1953-> |
HolmerCraig A |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Lungs - Transplantation |
Lungs - Diseases - Treatment |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Primary graft dysfunction in lung transplantation / S.F. Marasco ... [et al.] -- Intensive care management of the lung transplant recipient / Paolo Feltracco ... [et al.] -- Impact of viral pathogens in lung transplant recipients / Cristina Costa ... [et al.] -- Identification of allo- and auto-antibodies after lung transplantation / A.W.M. Paantjens ... [et al.] -- Surgical aspects of lung transplantation / Silvana Marasco ... [et al.] -- Neurologic complications of lung transplantation / Sasha Zivkovic -- Leucocyte intracellular cytokines in lung transplantation patients : a more physiological indicator of immunosuppression than plasma drug levels / Gred Hodge ... [et al.] -- Measurement of intracellular cytokines to improve therapeutic monitoring of immunosuppressive drugs following lung transplantation / Greg Hodge ... [et al.]. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Lung transplantation (LT) is the only definitive treatment for many forms of end-stage pulmonary diseases. However, its success is limited by several factors including organ infection/disease, acute rejection and chronic allograft dysfunction. Progresses made in patient selection, surgical techniques as well as in therapeutic management (immunosuppressive regimes) have led to a growing increase in the one-year survival rates up to 75%, however, the 5-year survival rate following LT remains only approximately 50%. This book presents |
|
|
|
|